Long-term cyclosporin for psoriasis. 1989

C E Griffiths, and A V Powles, and J McFadden, and B S Baker, and H Valdimarsson, and L Fry
Department of Dermatology, St Mary's Hospital, London, U.K.

Thirteen patients with severe persistent psoriasis, intolerant of, or unresponsive to, other current treatments have been treated with cyclosporin (Cys) for periods varying from 12-25 (mean 18) months. The dose ranged from 1-4 mg/kg/day (mean 2.8 mg). There was a 72% reduction in the mean PASI score at 4 weeks, and at the end of the study, an 81% reduction. Adjuvant therapy with topical steroids was used in 11 of the 13 patients after the first 3 months of Cys treatment to persistent patches on an intermittent basis with beneficial effect. Six patients developed mild to moderate hypertension, in three this was controlled by a reduction in the dose of Cys, and in the other three by hypotensive agents. The mean serum creatinine rose from 72 to 90 microM/l during the study. Hypertrichosis occurred in seven of the 13 patients. Low dosage Cys is an effective treatment for clearing psoriasis and maintaining improvement on a long-term basis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

C E Griffiths, and A V Powles, and J McFadden, and B S Baker, and H Valdimarsson, and L Fry
January 1989, Acta dermato-venereologica. Supplementum,
C E Griffiths, and A V Powles, and J McFadden, and B S Baker, and H Valdimarsson, and L Fry
January 1989, Acta dermato-venereologica. Supplementum,
C E Griffiths, and A V Powles, and J McFadden, and B S Baker, and H Valdimarsson, and L Fry
April 2003, The Journal of dermatology,
C E Griffiths, and A V Powles, and J McFadden, and B S Baker, and H Valdimarsson, and L Fry
March 2002, Clinical and experimental dermatology,
C E Griffiths, and A V Powles, and J McFadden, and B S Baker, and H Valdimarsson, and L Fry
May 1990, The British journal of dermatology,
C E Griffiths, and A V Powles, and J McFadden, and B S Baker, and H Valdimarsson, and L Fry
April 1992, Journal of autoimmunity,
C E Griffiths, and A V Powles, and J McFadden, and B S Baker, and H Valdimarsson, and L Fry
July 1994, The British journal of dermatology,
C E Griffiths, and A V Powles, and J McFadden, and B S Baker, and H Valdimarsson, and L Fry
February 2000, Annales de dermatologie et de venereologie,
C E Griffiths, and A V Powles, and J McFadden, and B S Baker, and H Valdimarsson, and L Fry
June 1991, Lancet (London, England),
C E Griffiths, and A V Powles, and J McFadden, and B S Baker, and H Valdimarsson, and L Fry
November 1989, Archives of dermatology,
Copied contents to your clipboard!